Deseret Mutual Benefit Administrators Has $167,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Deseret Mutual Benefit Administrators increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 10.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 17,888 shares of the pharmacy operator’s stock after buying an additional 1,620 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in Walgreens Boots Alliance were worth $167,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. First Financial Corp IN increased its position in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at about $28,000. TD Private Client Wealth LLC increased its holdings in Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Finally, Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth approximately $30,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on WBA. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Bank of America raised their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.63.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $10.16 on Friday. The firm has a 50 day moving average price of $10.37 and a 200-day moving average price of $9.71. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.